If you haven't been to our website lately, you may want to pay a visit http://www.smallcapreview.com . You will find free tech charts, resources, educational material, volume and market leaders for both the OTC and major exchanges,  financial tools, publicly traded companies by state and of course all the latest articles pertaining to small-cap stocks from around the world. Don't forget to bookmark and don't forget to tell your friends.

Biophan and NASA Ames Research Center for Nanotechnology Announce Joint Development Agreement...(BIPH)

IBSG International Announces Second Quarter Results Showing Cash Flow Positive $358,845...(IGII)

Investment Bugs Catching Nanotechnology Fever...(PFNH)

Biophan Technologies (BIPH)

Press Release: Biophan and NASA Ames Research Center for Nanotechnology Announce Joint Development Agreement

Biophan Technologies, Inc., announced today that its TE-Bio subsidiary has signed an agreement with NASA for characterization and joint development of high-density, nanoengineered thermoelectric materials for use with implantable medical devices. Research will be conducted at the NASA Ames Research Center for Nanotechnology in Moffett Field, CA.

To view the full Press Release please visit http://biz.yahoo.com/bw/040817/175765_1.html

Intelligent Business Systems Group (IGII)

Press Release: IBSG International Announces Second Quarter Results Showing Cash Flow Positive $358,845

The Company reported total assets of $3,466,956 which was an increase of 288% compared to the total assets of $1,203,530 as reported in the first quarter of 2004. The increase was due to the reporting of $1,730,000 of accounts receivables during the quarter, after reporting no accounts receivable in the first quarter of 2004, and the completed acquisition of the intellectual property of Red Hand International Inc. Liabilities decreased by 49.26% from $1,069,458 in the first quarter of 2004 to $542,641 in the second quarter due primarily to the extinguishment of related party debt. Shareholder's equity increased by 1490% to $1,999,889 from $134,072 in the first quarter.

To view the full Press Release please visit http://biz.yahoo.com/bw/040817/175571_1.html

To view the complete profile on IGII please visit http://www.smallcapreview.com/igii.htm

Perfisans Networks  (PFNH)

Press Release: Investment Bugs Catching Nanotechnology Fever

AXcess News released a story covering the wave of investor interest in the nanotechnology research sector and thanks to research made available by Lux Research, investors are getting validation of what micro cap nanotechnology companies, Biophan (OTC BB: BIPH), Isonics (NasdaqSC: ISON) and Perfisans (OTC BB: PFNH) have been saying all along.

To view the full Press Release please visit http://biz.yahoo.com/iw/040818/071500.html

To view the complete profile on PFNH please visit http://www.smallcapreview.com/pfnh.htm

Disclaimer

SmallCapReview.com feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. For continuing coverage of IGII, PFNH and BIPH please sign up for our free newsletter, SmallCapReview.com News. Information contained in this report was extracted from current documents filed with the SEC, the Company website and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our website. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. This is an advertisement for the above mentioned companies. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

Copyright SmallCapReview.com. All rights reserved. SmallCapReview.com is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our website and individual reports released to the public through this website, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our website or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility, particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our website or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com will disclose in its disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the SmallCapReview.com website. SmallCapReview.com has been compensated eight thousand dollars by a third party for its efforts in presenting the Intelligent Business Systems profile on its website and distributing it to its database of subscribers. SmallCapReview.com has been compensated eleven thousand dollars by a third party for its efforts in presenting the Biophan Technologies profile on its website and distributing it to its database of subscribers. SmallCapReview.com has been compensated three thousand dollars by a third party for its efforts in presenting the Perfisans Networks Inc., profile on its website and distributing it to its database of subscribers. SmallCapReview.com may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report. Information presented on our website and within our reports contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as ???expects??™???, ???will,??? ???anticipates,??? ???estimates, ???believes,??? or that by statements indicating certain actions ???may,??? ???could,??? or ???might??? occur.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SMALL CAP SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

We encourage our readers to invest carefully and read the investor information available at the websites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its website.